Indeed, in patients with basal and squamous cell carcinoma treated with PD-1 blockade, the T-cell response was shown to be derived from a specific repertoire of T-cell clones that enter the tumor, indicating that recruitment of T cells from the draining lymph nodes contributes to the response after PD-1 blockade (25). The gene discussed is PDCD1; the disease is squamous cell carcinoma.